Applicant, as named in the Orange Book

Mylan Spclt Viatris

Viatris Inc · Nasdaq: VTRS

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis

None.

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Dipentum NDA 019715 olsalazine sodium	olsalazine sodium	open now no listed protection	no listed protection